A Novel Mutation in the INSR Gene Causes Severe Insulin Resistance and Rabson–Mendenhall Syndrome in a Paraguayan Patient
Authors:
- Maria Natalia Rojas VelazquezMVMaria Natalia Rojas Velazquez
- Fabiola BlancoFBFabiola Blanco
- Ana Ayala-LugoAAAna Ayala-Lugo
- Lady FrancoLFLady Franco
- Valerie JollyVJValerie Jolly
- Denisse Di ToreDTDenisse Di Tore
- Idoia Martínez de LapiscinaILIdoia Martínez de Lapiscina
- Marco JannerMJMarco Janner
- Christa E. FlückCFChrista E. Flück
- Amit V. PandeyAmit V. Pandey
Open Access
- 8 March 2024
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (6) , 3143
Abstract
Rabson–Mendenhall syndrome (RMS) is a rare autosomal recessive disorder characterized by severe insulin resistance, resulting in early-onset diabetes mellitus. We report the first case of RMS in a Paraguayan patient. The patient is a 6-year-old girl who presented with hypertrichosis, acanthosis nigricans, nephrocalcinosis, and elevated levels of glucose and insulin that served as diagnostic indicators for RMS. Genetic testing by next-generation sequencing (NGS) revealed two pathogenic variants in exons 2 and 19 of the INSR gene: c.332G>T (p.Gly111Val) and c.3485C>T (p.Ala1162Val), in combined heterozygosis. The novel INSR c. 332G>T variant leads to the substitution of glycine to valine at position 111 in the protein, and multiple in silico software programs predicted it as pathogenic. The c.3485C>T variant leads to the substitution of alanine to valine at position 1162 in the protein previously described for insulin resistance and RMS. The management of RMS is particularly challenging in children, and the use of metformin is often limited by its side effects. The patient was managed with nutritional measures due to the early age of onset. This report expands the knowledge of RMS to the Paraguayan population and adds a novel pathogenic variant to the existing literature.Keywords
All Related Versions
Funding Information
- Swiss Government Excellence Scholarship (ESKAS) (2020.0557)
- University of Bern and swissuniversities (2020.0557)
This publication has 44 references indexed in Scilit:
- Genetic Variants in Human Sterol Regulatory Element Binding Protein-1c in Syndromes of Severe Insulin Resistance and Type 2 DiabetesDiabetes, 2004
- SIFT: predicting amino acid changes that affect protein functionNucleic Acids Research, 2003
- Genetic variants of insulin receptor substrate-1 (IRS-1) in syndromes of severe insulin resistance. Functional analysis of Ala513Pro and Gly1158Glu IRS-1Diabetic Medicine, 2002
- Two aberrant splicings caused by mutations in the insulin receptor gene in cultured lymphocytes from a patient with Rabson-Mendenhall's syndrome.Journal of Clinical Investigation, 1998
- Crystal structure of the activated insulin receptor tyrosine kinase in complex with peptide substrate and ATP analogThe EMBO Journal, 1997
- Substitution of glutamic acid for alanine 1135 in the putative “catalytic loop” of the tyrosine kinase domain of the human insulin receptor. A mutation that impairs proteolytic processing into subunits and inhibits receptor tyrosine kinase activity.Journal of Biological Chemistry, 1993
- Substitution of lysine for asparagine at position 15 in the alpha-subunit of the human insulin receptor. A mutation that impairs transport of receptors to the cell surface and decreases the affinity of insulin binding.Journal of Biological Chemistry, 1990
- Insulin-Receptor Biosynthesis in Cultured Lymphocytes From an Insulin-Resistant Patient (Rabson-Mendenhall Syndrome): Evidence for Defect Before Insertion of Receptor Into Plasma MembraneDiabetes, 1986
- Decreased Insulin Binding to Cultured Cells from a Patient with the Rabson-Mendenhall Syndrome: Dichotomy between Studies with Cultured Lymphocytes and Cultured Fibroblasts*The Journal of Clinical Endocrinology & Metabolism, 1983
- Familial Hypertrophy of Pineal Body, Hyperplasia of Adrenal Cortex and Diabetes Mellitus: Report of 3 CasesAmerican Journal of Clinical Pathology, 1956